# Hypodermic Needle Market > Hypodermic Needle Market Research Report: Size, Share, Trend Analysis By Needle Diameter (26 Gauge, 27 Gauge, 28 Gauge, 30 Gauge, 31 Gauge), By Needle Length (1/2 inch, 5/8 inch, 1 inch, 1 1/2 inch, 2 inch), By Needle Point Type (Sharp Point, Blunt Point, Pencil Point, Reverse Bevel Point, Luer Slip Point), By Needle Hub Type (Luer Lock Hub, Slip-On Hub, Threaded Hub, Eccentric Hub), By Needle Material (Stainless Steel, Plastic, Glass, Ceramic) and By Regional (North America, Europe, South America, Asia-Pacific, Middle East and Africa) - Growth Outlook & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 3.42% - **2024:** $ 4.96 Billion - **2025:** $ 5.13 Billion - **2035:** $ 7.19 Billion - **Key Players:** Becton Dickinson and Company (US), Terumo Corporation (JP), Smiths Medical (US), Nipro Corporation (JP), Medtronic plc (IE), Cardinal Health, Inc. (US), Fresenius Kabi AG (DE), Hollister Incorporated (US), Vygon S.A. (FR), MediPoint (US) **Report ID:** MRFR/HC/39097-HCR · **Pages:** 100 · **Author:** Rahul Gotadki · **Last Updated:** April 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/hypodermic-needle-market-41146 --- ## Market Summary ## **Global Hypodermic Needle Market Overview** As per MRFR analysis, the Hypodermic Needle Market Size was estimated at 4.65 (USD Billion) in 2022. The Hypodermic Needle Market Industry is expected to grow from 4.8(USD Billion) in 2023 to 6.5 (USD Billion) by 2032. The Hypodermic Needle Market CAGR (growth rate) is expected to be around 3.42% during the forecast period (2024 - 2032). ### **Key Hypodermic Needle Market Trends Highlighted** The Hypodermic Needle Market appears to be expanding quickly owing to robust technological advancements and the rising demand for chronic illness management solutions. The increasing prevalence of the elderly population, as well as the global penetration of emerging markets, all play an essential role in bringing about transformation. New advancements in depression therapy, such as the discovery of new chronic pain medical treatments, as well as increased use of home care devices and geriatric patients, have all contributed to the growth of the market. It also extended opportunities for the development of improved safety-enhanced needles and improved needle coatings and material and also focused on integrating smart technologies For tracking the needles. Trends such as the use of single-use needles focus on ultra-fine needles and [needle-free injection](../../../reports/needle-free-injection-market-6180) systems for enhanced patient comfort support, minimizing infection risks and needle trauma. These innovations aim to augment patient safety, lessen discomfort during procedures, and improve healthcare result that boosts the growth of the hypodermic needle market in the ongoing years. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ## **Hypodermic Needle Market Drivers** ### Rising Prevalence of Chronic Diseases The increasing prevalence of chronic diseases, such as diabetes, cardiovascular diseases, and cancer, is driving the demand for hypodermic needles. These diseases require regular injections of medication, which necessitates the use of safe and reliable needles. Hypodermic needles are essential for administering these medications accurately and effectively, ensuring optimal patient outcomes. The growing number of patients with chronic conditions is expected to continue to fuel the demand for hypodermic needles in the coming years. ### Technological Advancements in Needle Design Technological advancements in needle design are another key driver of the Hypodermic Needle Market Industry. Manufacturers are constantly innovating to develop needles that are less painful, more precise, and more efficient. For instance, the introduction of atraumatic needles with beveled tips has significantly reduced patient discomfort during injections. Similarly, the development of needles with smaller diameters and thinner walls allows for easier penetration and less tissue damage.These advancements enhance the patient experience and contribute to the growing adoption of hypodermic needles. ### Increasing Focus on Patient Safety The increasing focus on patient safety has also played a significant role in driving the demand for hypodermic needles. Governments and healthcare organizations worldwide are implementing stringent regulations to ensure the safe and effective use of medical devices. This has led to a greater emphasis on the quality and safety of hypodermic needles. Manufacturers are required to adhere to strict manufacturing standards and undergo rigorous testing to ensure that their products meet the required safety criteria.The growing awareness of patient safety concerns has contributed to the demand for high-quality and reliable hypodermic needles. ## **Hypodermic Needle Market Segment Insights** ### **Hypodermic Needle Market Needle Diameter Insights  ** The Hypodermic Needle Market segmentation by Needle Diameter is anticipated to showcase considerable growth potential in the years to come, driven by factors such as the increasing prevalence of chronic diseases, rising demand for minimally invasive procedures, and technological advancements in needle design. The market is segmented into various needle diameters, including 26 Gauge, 27 Gauge, 28 Gauge, 30 Gauge, and 31 Gauge, each catering to specific medical applications. Among these, 26 Gauge needles are widely used for intramuscular injections, blood collection, and subcutaneous injections due to their larger diameter and ability to accommodate higher flow rates.27 Gauge needles, on the other hand, offer a balance between flow rate and patient comfort, making them suitable for subcutaneous injections, intravenous infusions, and blood draws. 28 Gauge needles are commonly employed for intradermal injections, while 30 Gauge needles are preferred for delicate procedures such as insulin injections and vaccinations. 31 Gauge needles, with their ultra-fine diameter, are ideal for applications requiring minimal tissue trauma, such as intradermal testing and cosmetic procedures. The Hypodermic Needle Market revenue for 27 Gauge needles is projected to reach $750 million by 2024, capturing a significant share of the overall market. The growing demand for minimally invasive procedures, coupled with the increasing prevalence of chronic diseases, is expected to drive the growth of this segment. Furthermore, technological advancements, such as the development of atraumatic needles designed to minimize pain and tissue damage, are anticipated to fuel market expansion in the coming years. Overall, the Needle Diameter segment of the Hypodermic Needle Market presents immense opportunities for growth, with each diameter catering to specific medical applications and offering unique advantages.The increasing demand for minimally invasive procedures, coupled with technological advancements and the rising prevalence of chronic diseases, is expected to propel the growth of this market segment in the years to come. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ### **Hypodermic Needle Market Needle Length Insights  ** The needle length segment plays a significant role in the Hypodermic Needle Market. Different needle lengths cater to specific medical applications and patient needs. Among the mentioned needle lengths, 1/2 inch and 5/8 inch are commonly used for intradermal and subcutaneous injections, respectively. These shorter needles are preferred for vaccinations, allergy testing, and insulin administration. In contrast, longer needles like 1 inch, 1 1/2 inch, and 2 inch are utilized for intramuscular and intravenous injections. These needles provide deeper penetration, reaching muscles or veins for medication delivery or blood collection.The Hypodermic Needle Market data indicates that in 2024, the 1/2 inch segment held a significant market share, followed by 5/8 inch. The growth in this segment can be attributed to the increasing prevalence of chronic diseases and the rising demand for self-injection therapies. Furthermore, the market segmentation and insights highlight the importance of needle length in ensuring patient safety and comfort during medical procedures, driving the continued growth of this segment in the Hypodermic Needle Market industry. ### **Hypodermic Needle Market Needle Point Type Insights  ** The Hypodermic Needle Market segmentation by Needle Point Type comprises Sharp Point, Blunt Point, Pencil Point, Reverse Bevel Point, and Luer Slip Point. In 2023, the Sharp Point segment held the largest market share of 45%, owing to its wide usage in injections and blood collection. The Blunt Point segment is projected to exhibit the highest CAGR of 4.2% during the forecast period, driven by its increasing adoption in applications such as insulin delivery and vaccinations. The Pencil Point segment accounted for a market share of 22% in 2023 and is expected to witness steady growth due to its precision in delivering medications and fluids.The Reverse Bevel Point segment held a share of 18% in 2023 and is anticipated to maintain its position in the market. The Luer Slip Point segment accounted for a share of 15% in 2023 and is projected to experience moderate growth over the forecast period. ### **Hypodermic Needle Market Needle Hub Type Insights  ** Needle Hub Type segments the Hypodermic Needle Market into Luer Lock Hub, Slip-On Hub, Threaded Hub, and Eccentric Hub. Among these, the Luer Lock Hub segment held the largest market share in 2023 and is projected to maintain its dominance throughout the forecast period. The Luer Lock Hub type provides a secure and leak-proof connection between the needle and syringe, making it the preferred choice for critical applications such as drug delivery and blood collection. The Slip-On Hub segment is anticipated to witness steady growth owing to its ease of use and affordability.The Threaded Hub and Eccentric Hub segments are expected to account for a smaller share of the market but are projected to grow at a moderate pace due to their specific applications in specialized medical procedures. ### **Hypodermic Needle Market Needle Material Insights  ** The Hypodermic Needle Market segmentation by Needle Material comprises Stainless Steel, Plastic, Glass, and Ceramic. Stainless Steel held the largest market share in 2023, owing to its durability, cost-effectiveness, and resistance to corrosion. Plastic needles are gaining popularity due to their low cost, disposability, and transparency, which allow for easy visualization of the injection process. Glass needles offer high precision and chemical inertness, making them suitable for specialized applications. Ceramic needles are emerging as a promising alternative due to their high strength, biocompatibility, and resistance to wear and tear. ### **Hypodermic Needle Market Regional Insights  ** The Hypodermic Needle Market is segmented into North America, Europe, Asia-Pacific, South America, and the Middle East and Africa. North America is the largest regional market for hypodermic needles, followed by Europe and Asia-Pacific. The growth of the North American market is attributed to the increasing prevalence of chronic diseases, the rising demand for minimally invasive procedures, and the presence of major market players. The European market is also expected to grow significantly due to the increasing adoption of advanced healthcare technologies and the growing demand for home healthcare services.The Asia-Pacific market is expected to witness the fastest growth over the forecast period due to the rising healthcare expenditure, the increasing prevalence of infectious diseases, and the growing demand for affordable healthcare solutions. South America, the Middle East, and Africa are expected to experience moderate growth due to the limited healthcare infrastructure and the low penetration of advanced medical technologies. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ## **Hypodermic Needle Market Key Players And Competitive Insights** Major players in the Hypodermic Needle Market industry are constantly striving to develop new and innovative products to meet the evolving needs of the market. Leading Hypodermic Needle Market players are investing heavily in research and development to improve the safety, efficacy, and convenience of their products. The Hypodermic Needle Market industry is characterized by intense competition, with a number of leading players vying for market share. The competitive landscape is expected to remain fragmented over the forecast period, with no single player holding a dominant position.Terumo Corporation is a leading global provider of medical devices, including hypodermic needles. The company has a strong track record of innovation and is committed to providing high-quality products that meet the needs of its customers. Terumo Corporation has a wide range of hypodermic needles available, including needles for a variety of applications, such as injections, blood collection, and IV therapy. The company's needles are known for their sharpness, durability, and safety. Terumo Corporation Hypodermic Needle Market development efforts are focused on improving the safety and efficacy of its needles, as well as developing new needles for emerging applications.Becton, Dickinson and Company (BD) is another leading player in the Hypodermic Needle Market industry. BD is a global medical technology company that produces a wide range of products, including hypodermic needles. The company is committed to providing innovative and high-quality products that meet the needs of its customers. BD's hypodermic needles are available in a variety of sizes and gauges and are designed to meet the specific needs of each application. The company's needles are known for their sharpness, durability, and safety. BD is constantly investing in research and development to improve the safety and efficacy of its needles, as well as developing new needles for emerging applications. ## **Key Companies in the Hypodermic Needle Market Include** - Medtronic plc - **[Terumo Corporation](https://www.terumotmp.com/products/hypodermics/terumo-hypodermic-needles.html)** - AmerisourceBergen Corporation - Nipro Corporation - Boston Scientific Corporation - Fresenius Kabi AG - Owens Minor, Inc. - Henry Schein, Inc. - Becton, Dickinson and Company - Smiths Group plc - Braun Melsungen AG - **[Cardinal Health](https://www.cardinalhealth.com/en/product-solutions/medical/patient-care/sharps-safety/medication-delivery/standard-needles-and-syringes/hypodermic-needles.html)** - Baxter International Inc. - McKesson Corporation ## Hypodermic Needle Market Industry Developments - **Q1 2024: BD Launches UltraSafe Plus™ 2.25 mL Passive Needle Guard for Pre-Filled Syringes** BD announced the launch of its UltraSafe Plus™ 2.25 mL Passive Needle Guard, designed to enhance safety for healthcare workers and patients during drug administration with pre-filled syringes. - **Q2 2024: Terumo Opens New Manufacturing Facility in Vietnam to Expand Hypodermic Needle Production** Terumo Corporation inaugurated a new manufacturing plant in Vietnam to increase its production capacity for hypodermic needles, aiming to meet rising global demand. - **Q2 2024: Owen Mumford Launches Unifine® SafeControl® Pen Needles in Europe** Owen Mumford introduced its Unifine® SafeControl® pen needles in several European markets, targeting improved safety and ease of use for insulin-dependent patients. - **Q2 2024: Novo Nordisk Announces Partnership with Ypsomed for Next-Generation Pen Needles** Novo Nordisk entered a partnership with Ypsomed to co-develop next-generation pen needles, focusing on enhanced safety features and compatibility with insulin delivery devices. - **Q3 2024: HTL-STREFA Receives CE Mark Approval for Safety Hypodermic Needle** HTL-STREFA announced it has received CE Mark approval for its new safety hypodermic needle, enabling commercialization in the European Union. - **Q3 2024: Cardinal Health Expands Hypodermic Needle Portfolio with Launch of Safety-Engineered Products** Cardinal Health launched a new line of safety-engineered hypodermic needles designed to reduce the risk of needlestick injuries in clinical settings. - **Q3 2024: B. Braun Opens New R&D Center Focused on Hypodermic Needle Innovation** B. Braun inaugurated a research and development center dedicated to advancing hypodermic needle technology, with a focus on safety and patient comfort. - **Q4 2024: DeRoyal Announces Strategic Partnership with U.S. Hospital Network for Hypodermic Needle Supply** DeRoyal entered a strategic partnership with a major U.S. hospital network to supply hypodermic needles, aiming to improve supply chain reliability and product quality. - **Q4 2024: BD Secures Large-Scale Contract with UK NHS for Safety Hypodermic Needles** BD won a significant contract to supply safety hypodermic needles to the UK National Health Service, supporting national efforts to reduce needlestick injuries. - **Q1 2025: Artsana S.p.A. Launches Eco-Friendly Hypodermic Needle Line** Artsana S.p.A. introduced a new line of eco-friendly hypodermic needles, featuring recyclable materials and reduced environmental impact. - **Q2 2025: Trividia Health Announces FDA Clearance for New Hypodermic Needle Product** Trividia Health received FDA clearance for its latest hypodermic needle product, enabling U.S. market entry and expanding its medical device portfolio. - **Q2 2025: Perrigo Company plc Appoints New CEO to Drive Growth in Medical Devices Segment** Perrigo Company plc announced the appointment of a new CEO, with a mandate to accelerate growth in its medical devices segment, including hypodermic needles. ## **Hypodermic Needle Market Segmentation Insights** ### **Hypodermic Needle Market Needle Diameter Outlook** - 26 Gauge - 27 Gauge - 28 Gauge - 30 Gauge - 31 Gauge ### **Hypodermic Needle Market Needle Length Outlook** - 1/2 inch - 5/8 inch - 1 inch - 1 1/2 inch - 2 inch ### **Hypodermic Needle Market Needle Point Type Outlook** - Sharp Point - Blunt Point - Pencil Point - Reverse Bevel Point - Luer Slip Point ### **Hypodermic Needle Market Needle Hub Type Outlook** - Luer Lock Hub - Slip-On Hub - Threaded Hub - Eccentric Hub ### **Hypodermic Needle Market Needle Material Outlook** - Stainless Steel - Plastic - Glass - Ceramic ### **Hypodermic Needle Market Regional Outlook** - North America - Europe - South America - Asia-Pacific - Middle East and Africa ## Market Drivers ### Advancements in Needle Technology Technological innovations in needle design and materials are significantly influencing the Hypodermic Needle Market. Recent advancements include the development of safety-engineered needles that minimize the risk of needlestick injuries, which are a major concern for healthcare professionals. The introduction of features such as retractable needles and needle shields has enhanced safety and usability, thereby increasing adoption rates among healthcare providers. Additionally, the use of biocompatible materials in needle manufacturing has improved patient comfort and reduced adverse reactions. Market data suggests that the safety needle segment is expected to witness a compound annual growth rate of over 8% in the coming years. These advancements not only improve patient outcomes but also drive the demand for hypodermic needles, positioning the Hypodermic Needle Market for continued expansion. ### Increase in Home Healthcare Services The rise of home healthcare services is transforming the landscape of the Hypodermic Needle Market. As more patients opt for at-home treatments, the need for hypodermic needles for self-administration of medications is increasing. This trend is particularly evident among patients with chronic conditions who require regular injections, such as insulin for diabetes management. The convenience and comfort of receiving care at home are driving this shift, leading to a higher demand for user-friendly hypodermic needles. Market data indicates that the home healthcare market is projected to grow at a compound annual growth rate of over 7% in the coming years. This growth is likely to translate into increased sales of hypodermic needles, as healthcare providers adapt to the changing preferences of patients. Thus, the increase in home healthcare services is a significant driver for the Hypodermic Needle Market. ### Rising Incidence of Chronic Diseases The increasing prevalence of chronic diseases such as diabetes, cardiovascular disorders, and cancer is a primary driver of the Hypodermic Needle Market. As these conditions require regular monitoring and treatment, the demand for hypodermic needles is expected to rise. According to recent data, the number of individuals diagnosed with diabetes alone is projected to reach 700 million by 2045, necessitating a substantial supply of hypodermic needles for insulin administration. This trend indicates a growing market for hypodermic needles, as healthcare providers seek efficient and reliable delivery methods for medications. Furthermore, the aging population, which is more susceptible to chronic illnesses, further amplifies the need for these devices. Thus, the rising incidence of chronic diseases is likely to sustain the growth of the Hypodermic Needle Market. ### Growing Focus on Immunization Programs The Hypodermic Needle Industry. Governments and health organizations are increasingly prioritizing vaccination initiatives to combat infectious diseases, which has led to a surge in the demand for hypodermic needles. For instance, the World Health Organization has set ambitious targets for vaccination coverage, aiming to immunize millions of children and adults against preventable diseases. This focus on immunization is expected to result in a significant increase in the consumption of hypodermic needles, as they are essential for vaccine delivery. Market analysis indicates that the demand for needles used in vaccination campaigns is likely to grow at a rate of approximately 6% annually. Consequently, the growing focus on immunization programs is anticipated to bolster the Hypodermic Needle Market in the foreseeable future. ### Regulatory Support for Medical Devices Regulatory frameworks supporting the development and distribution of medical devices are playing a pivotal role in shaping the Hypodermic Needle Market. Governments and health authorities are implementing policies that facilitate the approval and commercialization of innovative medical devices, including hypodermic needles. This regulatory support is crucial for manufacturers seeking to introduce new products that enhance safety and efficacy. For instance, streamlined approval processes for safety-engineered needles are encouraging companies to invest in research and development. Furthermore, regulatory bodies are increasingly emphasizing the importance of quality standards, which is likely to drive competition and innovation within the market. As a result, the supportive regulatory environment is expected to foster growth in the Hypodermic Needle Market, enabling manufacturers to meet the evolving needs of healthcare providers and patients. ## Future Outlook The Hypodermic Needle Market is projected to grow at a 3.42% CAGR from 2025 to 2035, driven by technological advancements, increasing healthcare needs, and rising demand for vaccinations. **New opportunities:** - Development of smart hypodermic needles with integrated sensors - Expansion into emerging markets with tailored product offerings - Partnerships with telehealth platforms for remote patient monitoring solutions By 2035, the Hypodermic Needle Market is expected to achieve robust growth and enhanced market positioning. ## Segment Insights ### By Needle Diameter: 26 Gauge (Largest) vs. 30 Gauge (Fastest-Growing) In the hypodermic needle market, the distribution of market share among different needle diameters reveals intriguing insights. The 26 gauge needle currently holds the largest share, owing to its prevalent use in various clinical applications, including vaccination and blood sampling. Following closely are the 27 and 28 gauge needles, which are favored for their balance of size and patient comfort, appealing to both healthcare professionals and patients alike. On the other end of the spectrum, 30 gauge needles are rapidly gaining traction due to their suitability for pediatric and delicate procedures. Analyzing growth trends, the hypodermic needle segment is seeing noteworthy shifts. The increasing preference for minimally invasive procedures and the rise in chronic disease management are driving demand, particularly for finer gauge needles that minimize trauma. Moreover, technological advancements in needle design have led to innovative products that enhance patient experience and safety, further bolstering growth in the 30 and 31 gauge needles as they cater to more specialized medical needs. 26 Gauge (Dominant) vs. 30 Gauge (Emerging) The 26 gauge hypodermic needle remains a dominant player in the market, recognized for its versatility and wide application range. Its thicker diameter allows for faster delivery of fluids, making it a go-to choice for blood donation and vaccinations. Healthcare providers appreciate its reliability and effectiveness in various settings. Conversely, the 30 gauge needle is emerging as a key player in the market, primarily due to its finer point and minimal discomfort, making it ideal for infants and patients with sensitive skin. Its growing acceptance in immunizations and other applications reflects the evolving health landscape where less traumatic options are sought. This increasing trend shows a shift towards patient-centric care, allowing the 30 gauge needle to carve out its niche. ### By Needle Length: 1 inch (Largest) vs. 5/8 inch (Fastest-Growing) The hypodermic needle market exhibits a diverse distribution in needle lengths, with the 1 inch segment holding the largest share due to its extensive use in various medical procedures. Following closely is the 5/8 inch needle, which is gaining traction among healthcare professionals for specific applications, allowing for precise injections in various patient populations. Other lengths such as 1/2 inch, 1/2 inch, and 2 inch segments also contribute to the market, but they cater to more niche segments of the healthcare market. 1 inch (Dominant) vs. 5/8 inch (Emerging) The 1 inch hypodermic needle is the dominant segment, favored for its versatility in administering both intramuscular and subcutaneous injections. This length is particularly popular in vaccinations and drug delivery, making it a staple in hospitals and clinics. Conversely, the 5/8 inch needle is rapidly emerging due to a growing preference for less invasive procedures. It is increasingly used in pediatric and geriatric care where shorter needles can enhance patient comfort while still providing effective drug delivery. The demand for the 5/8 inch needle is expected to rise as more healthcare providers shift towards patient-centric practices. ### By Needle Point Type: Sharp Point (Largest) vs. Blunt Point (Fastest-Growing) In the hypodermic needle market, the distribution of market share among needle point types shows sharp points as the leading segment, dominating overall sales due to their versatility and effectiveness in various medical applications. Blunt points, while currently smaller in share, are gaining traction owing to their increased safety profile, reducing the risk of needlestick injuries, particularly in specific healthcare settings. The growth trends for the needle point segment indicate a rising preference for blunt points driven by a heightened awareness of safety in medical practices, legislative moves towards safer options, and innovation in needle design. Sharp points continue to be favored for traditional applications, but the increasing demand for safety mechanisms provides a dual growth pathway within the segment, influencing manufacturers to diversify their offerings. Needle Point Type: Sharp Point (Dominant) vs. Blunt Point (Emerging) Sharp point needles are characterized by their fine, precision-tapered tips, providing optimal penetration for intravenous and intramuscular injections, which makes them appealing in hospital settings. Their dominance in the hypodermic needle market is anchored in their well-established usage and effectiveness across a range of applications. In contrast, blunt point needles are emerging as a significant player, particularly in applications where safety is paramount. With their design aimed at reducing injury risks, they are increasingly used in pediatric and mental health settings where needlestick injuries are a common concern. The evolving regulatory landscape that promotes safe practices and the innovations in medical devices are contributing to the growth of blunt point needles in the market. ### By Needle Hub Type: Luer Lock Hub (Largest) vs. Slip-On Hub (Fastest-Growing) The Hypodermic Needle Market's 'Needle Hub Type' segment exhibits competitive dynamics, with the Luer Lock Hub leading the market due to its widespread adoption and compatibility across various devices. The Slip-On Hub, while currently smaller in market share, is gaining traction rapidly as healthcare providers lean towards ease of use and efficiency. The Threaded and Eccentric Hubs hold niche positions but are essential in specialized applications that require precise alignments and secure connections. Luer Lock Hub (Dominant) vs. Slip-On Hub (Emerging) The Luer Lock Hub is recognized as the dominant player in the hypodermic needle market, attributed to its secure locking mechanism that reduces the likelihood of accidental disconnections, making it a preferred choice among healthcare professionals. Conversely, the Slip-On Hub is emerging rapidly due to its user-friendly design and cost-effectiveness, appealing particularly to markets with limited budgets. This segment's growth is driven by the demand for safer and easier-to-use products, making the Slip-On Hub an attractive alternative in various healthcare settings. In contrast, the Threaded and Eccentric Hubs cater to specific scenarios, confirming their importance despite a lower market share. ### By Needle Material: Stainless Steel (Largest) vs. Plastic (Fastest-Growing) The hypodermic needle market is diversified into several material types, among which stainless steel holds the largest market share due to its durability and biocompatibility. Sturdy and reliable, stainless steel needles have been the traditional choice in medical applications, dominating the market landscape. In contrast, plastic needles are recognized as the fastest-growing segment, driven by their low-cost production and increasing adoption in various healthcare applications, including self-injection systems and vaccinations. Material: Stainless Steel (Dominant) vs. Plastic (Emerging) Stainless steel needles are the backbone of the hypodermic needle market, owing to their superior mechanical strength and resistance to corrosion. They are widely used in hospitals and clinical settings for injections and blood draws, ensuring patient safety and comfort. On the other hand, plastic needles offer flexibility and are increasingly popular in home healthcare settings. Their lightweight nature and affordability make them attractive for disposable applications. This transition highlights a trend towards user-friendly options in patient care, reflecting rising consumer demand for convenience and hygiene in needle use. ## Regional Market Share Analysis The Hypodermic Needle Market is segmented into North America, Europe, Asia-Pacific, South America, and the Middle East and Africa. North America is the largest regional market for hypodermic needles, followed by Europe and Asia-Pacific. The growth of the North American market is attributed to the increasing prevalence of chronic diseases, the rising demand for minimally invasive procedures, and the presence of major market players. The European market is also expected to grow significantly due to the increasing adoption of advanced healthcare technologies and the growing demand for home healthcare services.The Asia-Pacific market is expected to witness the fastest growth over the forecast period due to the rising healthcare expenditure, the increasing prevalence of infectious diseases, and the growing demand for affordable healthcare solutions. South America, the Middle East, and Africa are expected to experience moderate growth due to the limited healthcare infrastructure and the low penetration of advanced medical technologies. ## Competitive Benchmarking Major players in the Hypodermic Needle Market industry are constantly striving to develop new and innovative products to meet the evolving needs of the market. Leading Hypodermic Needle Market players are investing heavily in research and development to improve the safety, efficacy, and convenience of their products. The Hypodermic Needle Market industry is characterized by intense competition, with a number of leading players vying for market share. The competitive landscape is expected to remain fragmented over the forecast period, with no single player holding a dominant position.Terumo Corporation is a leading global provider of medical devices, including hypodermic needles. The company has a strong track record of innovation and is committed to providing high-quality products that meet the needs of its customers. Terumo Corporation has a wide range of hypodermic needles available, including needles for a variety of applications, such as injections, blood collection, and IV therapy. The company's needles are known for their sharpness, durability, and safety. Terumo Corporation Hypodermic Needle Market development efforts are focused on improving the safety and efficacy of its needles, as well as developing new needles for emerging applications.Becton, Dickinson and Company (BD) is another leading player in the Hypodermic Needle Market industry. BD is a global medical technology company that produces a wide range of products, including hypodermic needles. The company is committed to providing innovative and high-quality products that meet the needs of its customers. BD's hypodermic needles are available in a variety of sizes and gauges and are designed to meet the specific needs of each application. The company's needles are known for their sharpness, durability, and safety. BD is constantly investing in research and development to improve the safety and efficacy of its needles, as well as developing new needles for emerging applications. ## Recent News & Developments - **Q1 2024: BD Launches UltraSafe Plus™ 2.25 mL Passive Needle Guard for Pre-Filled Syringes** BD announced the launch of its UltraSafe Plus™ 2.25 mL Passive Needle Guard, designed to enhance safety for healthcare workers and patients during drug administration with pre-filled syringes. - **Q2 2024: Terumo Opens New Manufacturing Facility in Vietnam to Expand Hypodermic Needle Market Production** Terumo Corporation inaugurated a new manufacturing plant in Vietnam to increase its production capacity for hypodermic needles, aiming to meet rising global demand. - **Q2 2024: Owen Mumford Launches Unifine® SafeControl® Pen Needles in Europe** Owen Mumford introduced its Unifine® SafeControl® pen needles in several European markets, targeting improved safety and ease of use for insulin-dependent patients. - **Q2 2024: Novo Nordisk Announces Partnership with Ypsomed for Next-Generation Pen Needles** Novo Nordisk entered a partnership with Ypsomed to co-develop next-generation pen needles, focusing on enhanced safety features and compatibility with insulin delivery devices. - **Q3 2024: HTL-STREFA Receives CE Mark Approval for Safety Hypodermic Needle Market** HTL-STREFA announced it has received CE Mark approval for its new safety hypodermic needle, enabling commercialization in the European Union. - **Q3 2024: Cardinal Health Expands Hypodermic Needle Market Portfolio with Launch of Safety-Engineered Products** Cardinal Health launched a new line of safety-engineered hypodermic needles designed to reduce the risk of needlestick injuries in clinical settings. - **Q3 2024: B. Braun Opens New R&D Center Focused on Hypodermic Needle Market Innovation** B. Braun inaugurated a research and development center dedicated to advancing hypodermic needle technology, with a focus on safety and patient comfort. - **Q4 2024: DeRoyal Announces Strategic Partnership with U.S. Hospital Network for Hypodermic Needle Market Supply** DeRoyal entered a strategic partnership with a major U.S. hospital network to supply hypodermic needles, aiming to improve supply chain reliability and product quality. - **Q4 2024: BD Secures Large-Scale Contract with UK NHS for Safety Hypodermic Needles** BD won a significant contract to supply safety hypodermic needles to the UK National Health Service, supporting national efforts to reduce needlestick injuries. - **Q1 2025: Artsana S.p.A. Launches Eco-Friendly Hypodermic Needle Market Line** Artsana S.p.A. introduced a new line of eco-friendly hypodermic needles, featuring recyclable materials and reduced environmental impact. - **Q2 2025: Trividia Health Announces FDA Clearance for New Hypodermic Needle Market Product** Trividia Health received FDA clearance for its latest hypodermic needle product, enabling U.S. market entry and expanding its medical device portfolio. - **Q2 2025: Perrigo Company plc Appoints New CEO to Drive Growth in Medical Devices Segment** Perrigo Company plc announced the appointment of a new CEO, with a mandate to accelerate growth in its medical devices segment, including hypodermic needles. ## Report Scope | MARKET SIZE 2024 | 4.964(USD Billion) | | --- | --- | | MARKET SIZE 2025 | 5.134(USD Billion) | | MARKET SIZE 2035 | 7.186(USD Billion) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 3.42% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Billion | | Key Companies Profiled | Becton Dickinson and Company (US), Terumo Corporation (JP), Smiths Medical (US), Nipro Corporation (JP), Medtronic plc (IE), Cardinal Health, Inc. (US), Fresenius Kabi AG (DE), Hollister Incorporated (US), Vygon S.A. (FR), MediPoint (US) | | Segments Covered | Needle Diameter, Needle Length, Needle Point Type, Needle Hub Type, Needle Material, Regional | | Key Market Opportunities | Integration of smart technology in hypodermic needles enhances patient safety and monitoring capabilities. | | Key Market Dynamics | Rising demand for safety-engineered hypodermic needles drives innovation and regulatory compliance in the healthcare sector. | | Countries Covered | North America, Europe, APAC, South America, MEA | ## Frequently Asked Questions **Q: What is the current valuation of the Hypodermic Needle Market in 2025?** A: The Hypodermic Needle Market is valued at approximately 4.964 USD Billion in 2024. **Q: What is the projected market valuation for the Hypodermic Needle Market by 2035?** A: The market is projected to reach a valuation of 7.186 USD Billion by 2035. **Q: What is the expected CAGR for the Hypodermic Needle Market during the forecast period 2025 - 2035?** A: The expected CAGR for the Hypodermic Needle Market during the forecast period 2025 - 2035 is 3.42%. **Q: Which companies are considered key players in the Hypodermic Needle Market?** A: Key players in the market include Becton Dickinson and Company, Terumo Corporation, and Smiths Medical, among others. **Q: How does the market segment for Needle Diameter perform in terms of valuation?** A: The Needle Diameter segment shows valuations ranging from 0.746 to 1.824 USD Billion for various gauges. **Q: What are the projected valuations for the Needle Length segment by 2035?** A: The Needle Length segment is projected to have valuations between 0.746 and 1.982 USD Billion for different lengths. **Q: What is the performance of the Needle Point Type segment in the market?** A: The Needle Point Type segment indicates valuations from 0.7 to 2.2 USD Billion, depending on the point type. **Q: What are the expected valuations for the Needle Hub Type segment by 2035?** A: The Needle Hub Type segment is expected to show valuations ranging from 1.0248 to 2.0865 USD Billion. **Q: What materials are primarily used in the production of hypodermic needles?** A: The primary materials include Stainless Steel, Plastic, Glass, and Ceramic, with valuations from 0.5 to 2.2 USD Billion. **Q: How does the growth of the Hypodermic Needle Market reflect on healthcare advancements?** A: The growth of the Hypodermic Needle Market may reflect advancements in healthcare, driven by innovations from key players and increasing demand. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/hypodermic-needle-market-41146*